Literature DB >> 17114668

Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.

Sara M Tolaney1, Ann H Partridge, Rochelle G Sheib, Harold J Burstein, Eric P Winer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114668     DOI： 10.1200/JCO.2006.08.1083

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Pneumocystis jiroveci Pneumonia in an Atypical Host.

Authors:  Raquel E Reinbolt; Shadia Alam; Rachel Layman; Charles Shapiro; Maryam Lustberg
Journal:  Clin Breast Cancer       Date:  2011-12-01       Impact factor: 3.225

2.  Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.

Authors:  Ryan Brewster; Natasha Purington; Solomon Henry; Douglas Wood; Kristen Ganjoo; Nam Bui
Journal:  JAMA Netw Open       Date:  2021-03-01

3.  A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.

Authors:  Lynn Symonds; Isaac Jenkins; Hannah M Linden; Brenda Kurland; Julie R Gralow; Vijayakrishna V K Gadi; Georgiana K Ellis; Qian Wu; Eve Rodler; Pavani Chalasani; Xiaoyu Chai; Jinny Riedel; Alison Stopeck; Ursa Brown-Glaberman; Jennifer M Specht
Journal:  Clin Breast Cancer       Date:  2021-05-24       Impact factor: 3.225

4.  Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer.

Authors:  Kenji Tezuka; Kotaro Miura; Yusuke Nakano; Takahiro Ueda; Kyoko Yagyu; Shimako Matsuyama; Masami Shirai; Hiroshi Okuda; Miho Ujikawa; Takayo Ota
Journal:  World J Surg Oncol       Date:  2021-06-11       Impact factor: 2.754

5.  Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer.

Authors:  Tsuyoshi Shinohara; Makito Yasui; Hiroyuki Yamada; Yoshiro Fujimori; Kiyofumi Yamagishi
Journal:  Case Rep Oncol Med       Date:  2013-05-16

6.  A Multicenter Study of Docetaxel at a Dose of 100 mg/m2 in Japanese Patients with Advanced or Recurrent Breast Cancer.

Authors:  Taizo Hirata; Shinji Ozaki; Masahiro Tabata; Takayuki Iwamoto; Shiro Hinotsu; Akinobu Hamada; Takayuki Motoki; Tomohiro Nogami; Tadahiko Shien; Naruto Taira; Junji Matsuoka; Hiroyoshi Doihara
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

7.  Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.

Authors:  Anosheh Afghahi; Natasha Purington; Summer S Han; Manisha Desai; Emma Pierson; Maya B Mathur; Tina Seto; Caroline A Thompson; Joseph Rigdon; Melinda L Telli; Sunil S Badve; Christina N Curtis; Robert B West; Kathleen Horst; Scarlett L Gomez; James M Ford; George W Sledge; Allison W Kurian
Journal:  Clin Cancer Res       Date:  2018-03-26       Impact factor: 13.801
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.